Första AP-fonden’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Första AP-fonden’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,000	Closed	-$111K	–	547
2020 Q2	$111K	Buy	+9,000	New	+$102K	﹤0.01%	519
2017 Q3	–	Sell	-565,707	Closed	-$18.8M	–	344
2017 Q2	$18.8M	Hold	565,707	–	–	0.53%	53
2017 Q1	$18.2M	Hold	565,707	–	–	0.58%	49
2016 Q4	$20.5M	Sell	565,707 -23,800	-4%	-$950K	0.66%	45
2016 Q3	$27.1M	Sell	589,507 -43,600	-7%	-$2.27M	0.75%	36
2016 Q2	$31.8M	Buy	+633,107	New	+$33.7M	0.92%	32

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Första AP-fonden's TEVA Position: Q3 2020 in Review

Första AP-fonden sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2020, closing a stake of 9,000 shares — an estimated $111K sold.

Första AP-fonden first reported a position in TEVA in Q2 2016 and held it in 6 quarters. The position peaked at $31.8M in Q2 2016. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

Första AP-fonden reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2020 after selling out during the quarter.
Första AP-fonden sold 9,000 Teva Pharmaceutical Industries Limited shares in Q3 2020, an estimated $111K.
Första AP-fonden first reported a position in Teva Pharmaceutical Industries Limited in Q2 2016 and held it in 6 quarters.
Första AP-fonden's Teva Pharmaceutical Industries Limited position peaked at $31.8M in Q2 2016.
444 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2020.

Based on Första AP-fonden's 13F filing for Q3 2020, filed 22 Oct 2020.